These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2700881)

  • 1. [Therapy of cancer of the prostate in stage C].
    Escudero Barrilero A
    Arch Esp Urol; 1989; 42 Suppl 2():155-63. PubMed ID: 2700881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Controversy regarding the therapeutic management of stage B2, C and D1 adenocarcinoma].
    Escudero Barrilero A
    Arch Esp Urol; 1992 Sep; 45(7):621-37. PubMed ID: 1280071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined surgery and immediate adjuvant hormonal treatment for stage D1 adenocarcinoma of the prostate: Mayo Clinic experience.
    Zincke H
    Semin Urol; 1990 Aug; 8(3):175-83. PubMed ID: 2399386
    [No Abstract]   [Full Text] [Related]  

  • 4. [Present status and questions on early prostatic cancer (stage A, B)].
    Oishi K; Arai Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1991 Aug; 37(8):789-93. PubMed ID: 1957722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
    Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
    Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for stage C or D1 adenocarcinoma of the prostate: possible beneficial effect of adjuvant treatment.
    Zincke H
    NCI Monogr; 1988; (7):109-15. PubMed ID: 3173496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study on adenocarcinoma of the prostate].
    Yamamoto A; Yuasa M; Imagawa A; Kagawa S; Kurokawa K
    Hinyokika Kiyo; 1987 Dec; 33(12):2050-4. PubMed ID: 3448932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical excision of adenocarcinoma of prostate with pelvic lymph node involvement: surgical gesture or curative procedure.
    Utz DC
    Urology; 1984 Nov; 24(5 Suppl):4-11. PubMed ID: 6495469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic lymphadenectomy as staging before definitive treatment of prostatic carcinoma.
    Elfving P; Lundgren R
    Scand J Urol Nephrol Suppl; 1988; 110():155-61. PubMed ID: 3142034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy.
    Cadeddu JA; Partin AW; Epstein JI; Walsh PC
    Urology; 1997 Aug; 50(2):251-5. PubMed ID: 9255297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment results of radical prostatectomy in clinical stage B and C prostate cancer: comparison of the neoadjuvant therapy group versus the surgery group; retrospective analysis of 80 cases].
    Ogura Y; Sakata Y; Wakita T; Hayashi N; Hioki T; Sugimura Y
    Hinyokika Kiyo; 2003 Sep; 49(9):515-20. PubMed ID: 14598688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary surgical therapy for clinical stage T3 adenocarcinoma of the prostate.
    Amling CL; Leibovich BC; Lerner SE; Bergstralh EJ; Blute ML; Myers RP; Zincke H
    Semin Urol Oncol; 1997 Nov; 15(4):215-21. PubMed ID: 9421448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of 169 patients with prostate cancer].
    Okaneya T; Mizusawa H; Yoneyama T; Taguchi I; Komiyama I; Kawakami M; Hosaka K; Tsuruta T; Murata Y; Komatsu H; Misawa K; Kiyokawa H
    Hinyokika Kiyo; 1996 Aug; 42(8):563-7. PubMed ID: 8889563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
    J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radical prostatectomy in stage C prostatic cancer].
    Flamm J; Kiesswetter H
    Z Urol Nephrol; 1987 Mar; 80(3):185-9. PubMed ID: 3604476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
    Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
    J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.
    Zincke H; Lau W; Bergstralh E; Blute ML
    J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of complete androgen block before radical prostatectomy for cancer of the prostate].
    Gómez Veiga F; Lorenzo Patiño MJ; Díaz Bermúdez J; Duarte Novo J; Alvarez Castelo L; Chantada Abal V; Sánchez Rodríguez J; González Martín M
    Arch Esp Urol; 1997 May; 50(4):355-63. PubMed ID: 9313044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic markers in clinically localized prostate cancer.
    Pettaway CA
    Tech Urol; 1998 Mar; 4(1):35-42. PubMed ID: 9568775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of biochemical relapse for stage pT3 prostate cancer following radical prostatectomy.
    Wu TT; Wang JS; Lu CM; Lee YH; Huang JK
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):124-30. PubMed ID: 10677923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.